Arbutus Biopharma Corporation
ABUS
|
$2.79
-4.45%
-4.66%
710K
|
Health Technology
(0.0% 1d) (15.0% 1m) (-1.0% 1y) (0.0% 2d) (-1.7% 3d) (-3.6% 7d) (-82.24% volume)
Earnings Calendar: 2024-02-29
Market Cap: $ 500,783,235
http://www.arbutusbio.com
Sec Filling | Patents | 80 employees
(US) Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.
hepatitis injection
add to watch list Paper trade email alert is off
Press-releases
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
Published: 2024-04-04 (Crawled : 12:30) - globenewswire.com
MRNA | News S | $103.45 -0.33% -0.33% 2M
|
Health Technology
|
| O: 1.46%
H: 3.2%
C: -0.41%
ABUS | $2.79 -4.45% -4.66% 710K
|
Health Technology
|
| O: 16.73%
H: 6.14%
C: 2.39%
patent construction biopharma ongoing
Barinthus Bio Reports Full Year 2023 Financial Results and Update on Corporate Developments
Published: 2024-03-20 (Crawled : 12:00) - globenewswire.com
ABUS | $2.79 -4.45% -4.66% 710K
|
Health Technology
|
| O: -1.58%
H: 3.05%
C: 2.41%
year update financial results
Lipid-Nanoparticle Based Genomic Medicines Market worth $32.5 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
Published: 2024-03-18 (Crawled : 14:00) - prnewswire.com
CVAC | $2.57 -3.57% -3.7% 920K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -2.73%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 0.48%
H: 1.18%
C: 0.08%
ABUS | $2.79 -4.45% -4.66% 710K
|
Health Technology
|
| O: 0.38%
H: 0.38%
C: -3.42%
report genomic market
Arbutus to Participate in Two Upcoming Investor Conferences
Published: 2024-03-08 (Crawled : 12:30) - globenewswire.com
ABUS | $2.79 -4.45% -4.66% 710K
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
Arbutus to Participate in Two Upcoming Investor Conferences - March 8, 2024
Published: 2024-03-08 (Crawled : 14:30) - biospace.com/
ABUS | $2.79 -4.45% -4.66% 710K
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
Published: 2024-02-29 (Crawled : 12:30) - globenewswire.com
ROIV | $10.45 -2.43% -2.49% 4M
|
Manufacturing
|
| O: 1.2%
H: 0.34%
C: -3.46%
ABUS | $2.79 -4.45% -4.66% 710K
|
Health Technology
|
| O: -1.37%
H: 0.0%
C: -2.44%
year update financial results
Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update
Published: 2024-02-15 (Crawled : 12:30) - globenewswire.com
ABUS | $2.79 -4.45% -4.66% 710K
|
Health Technology
|
| O: 0.85%
H: 0.0%
C: -1.36%
report year update financial results
Arbutus Announces 2024 Corporate Objectives and Provides Financial Update
Published: 2024-01-08 (Crawled : 13:00) - globenewswire.com
ABUS | $2.79 -4.45% -4.66% 710K
|
Health Technology
|
| O: 3.32%
H: 3.21%
C: -1.61%
update financial
Barinthus Bio Presents Interim Data from Phase 2b HBV003 Trial and Phase 2a AB-729-202 Trial in Collaboration with Arbutus Biopharma in Chronic HBV Patients at AASLD
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
ABUS | $2.79 -4.45% -4.66% 710K
|
Health Technology
|
| O: 1.67%
H: 0.0%
C: -3.28%
hbv003 biopharma collaboration trial
Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at AASLD - The Liver Meeting®
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
ABUS | $2.79 -4.45% -4.66% 710K
|
Health Technology
|
| O: 1.67%
H: 0.0%
C: -3.28%
vtp-300 meeting liver biopharma trial
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Last 48 Hours Insiders Buying
IZEA | $2.5 -2.4% 8.6K
|
Technology Services
|
00:00
RKT P 383 | $11.38 -0.52% 1.05% 1.4M
|
Finance
|
22:30
CTRN P 18090 | $22.46 -1.01% -1.02% 55K
|
Retail Trade
|
22:00
BRN P 10650 | $2.795 2.38% 0.18% 35K
|
Energy Minerals
|
21:00
NEOG P 10000 | $12.14 -0.16% -0.16% 3.1M
|
Health Technology
|
16:30
RMCF | $3.51 -3.7% -3.85% 3.8K
|
Consumer Non-Durables
|
20:10